Adrian Krainer Archives - Cold Spring Harbor Laboratory

Newsstand Menu

Select stories by tag

Adrian Krainer wins Zülch Prize for lifesaving SMA Treatment

October 8, 2019

Professor Adrian Krainer is awarded the K-J. Zülch Prize for the development and testing of a first-of-its-kind treatment for spinal muscular atrophy.

Mutant cells team up to make an even deadlier blood cancer

October 2, 2019

Two very different mutations have been identified as unexpected partners-in-crime for causing the deadly blood cancer acute myeloid leukemia.

How one family secured the future of a laboratory

September 12, 2019

The Robertson family gifts to CSHL in the early 1970s were of extraordinary importance, for without them the Laboratory might not have survived.

Adrian Krainer wins RNA Society’s Lifetime Achievement Award

March 8, 2019

Professor Adrian Krainer was awarded the RNA Society’s Lifetime Achievement Award for his life-saving research.

National Academy of Inventors Fellow, Adrian Krainer

December 11, 2018

Professor Adrian Krainer has been named a NAI 2018 Fellow for his work on the first FDA-approved treatment for spinal muscular atrophy.

Big bold dreamers

December 10, 2018

Dreamers drive discoveries. CSHL honors its many scientists making big impacts in their respective fields.

Breakthrough Prize laureates meet at CSHL

December 6, 2018

Breakthrough Prize winner Adrian Krainer & C. Frank Bennett reunite for the first time since their award ceremony at CSHL to discuss further project.

Breakthrough Prize to CSHL professor for SMA research

October 17, 2018

Professor Adrian Krainer has received a Breakthrough Prize in Life Sciences for his work on the first FDA-approved treatment of SMA.

Predicting how splicing errors impact disease risk

August 30, 2018

New research helps correlate genetic mutations with errors in RNA splicing that can cause serious illness

CSHL helps ring opening bell at Nasdaq

August 21, 2018

CSHL Professor Adrian Krainer and his team join the Spinal Muscular Atrophy (SMA) Foundation in ringing the Nasdaq opening bell

Therapeutic RNA corrects splicing defect that causes familial dysautonomia

April 30, 2018

A team provides proof of concept for an RNA drug correcting an error in RNA splicing that causes familial dysautonomia (FD)

New method identifies splicing biomarkers for liver cancer

March 2, 2018

Researchers have developed a method for identifying splicing-based biomarkers for liver cancer

Welcome to the real world of science, I’ll be your guide

February 5, 2018

Jackie Novatt was determined to show the people on her campus tours how science really works—and landed her dream job in the process.

FDA approval of life-saving SMA drug is hailed by its researcher-inventor at CSHL

December 24, 2016

Nusinersen (Spinraza) will be used to treat young children with a severe and potentially fatal illness called spinal muscular atrophy (SMA).

One experiment: A drug for SMA visibly repairs defective cells

December 1, 2016

Professor Adrian Krainer develops a treatment for spinal muscular atrophy, the leading genetic cause of infant death.

CSHL Story archive for Tag: Adrian Krainer